[Neuropsychiatric symptoms in Sotos syndrome. Case report and review of the literature]

Neuropsychiatr. 2008;22(1):38-42.
[Article in German]

Abstract

Sotos syndrome, or cerebral gigantism, is a rare genetic syndrome characterized by excessive growth during childhood, macrocephaly, distinctive facial gestalt and learning difficulties. It is caused by mutations or deletions of the NSD-1 gene. Most cases are sporadic. Apart from a number of physical abnormalities that are commonly present, a high prevalence of cognitive, emotional and behavioural problems in children with Sotos syndrome can be assumed. However, there has been almost no literature about psychiatric symptoms in adults with Sotos syndrome so far; one case of psychosis was reported. In the present case, the authors present psychopathological features of an adult patient with Sotos syndrom who developed - among other things - psychotic symptoms.

Publication types

  • Case Reports
  • Review

MeSH terms

  • Adult
  • Antipsychotic Agents / therapeutic use
  • Brain / abnormalities*
  • Carbamazepine / therapeutic use
  • Chromosome Deletion
  • Citalopram / therapeutic use
  • Compulsive Behavior / diagnosis
  • Compulsive Behavior / drug therapy
  • Compulsive Behavior / genetics
  • Craniofacial Abnormalities / diagnosis*
  • Craniofacial Abnormalities / genetics
  • Drug Therapy, Combination
  • Facies
  • Female
  • Gigantism / diagnosis*
  • Gigantism / genetics
  • Hallucinations / diagnosis
  • Hallucinations / drug therapy
  • Hallucinations / genetics
  • Histone Methyltransferases
  • Histone-Lysine N-Methyltransferase
  • Humans
  • Intracellular Signaling Peptides and Proteins / genetics
  • Learning Disabilities / diagnosis*
  • Learning Disabilities / genetics
  • Neurocognitive Disorders / diagnosis*
  • Neurocognitive Disorders / drug therapy
  • Neurocognitive Disorders / genetics
  • Neuropsychological Tests
  • Nuclear Proteins / genetics
  • Risperidone / therapeutic use
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Syndrome

Substances

  • Antipsychotic Agents
  • Intracellular Signaling Peptides and Proteins
  • Nuclear Proteins
  • Serotonin Uptake Inhibitors
  • Citalopram
  • Carbamazepine
  • Histone Methyltransferases
  • Histone-Lysine N-Methyltransferase
  • NSD1 protein, human
  • Risperidone